Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02924714
Recruitment Status : Suspended (Slow accrual)
First Posted : October 5, 2016
Last Update Posted : February 18, 2022
Information provided by (Responsible Party):
Øyvind Sverre Bruland, Oslo University Hospital

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : November 2022